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Our study shows that the flies from the EMHWCC MDT 
colony are in fact L. sericata and not L. cuprina. This is what 
would be expected, as L. sericata is widely used in Europe and 
the USA for MDT.1
The issue of correct identification of these blowflies 
becomes a medical issue when they are used for MDT, and it 
is advisable to have adequate quality assurance criteria and 
protocols in place. The most reliable protocol is to sequence the 
DNA of these flies for a diagnostic gene. 
This study highlights the need for quality assurance 
protocols for identifying flies for MDT. It demonstrates that the 
nuclear 28S rRNA gene would be a good choice for this task, 
and suggests that qualified entomologists who specialise in 
DNA sequencing of flies assist in this matter.
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Regional clinical registry data show increased incidence of 
cutaneous melanoma in Cape Town
S Jessop, H Stubbings, R Sayed, J Duncan-Smith, J W Schneider, H F Jordaan
To the Editor: Cutaneous melanoma is a skin tumour that 
continues to result in a high mortality rate, particularly in 
the case of thick tumours and those that are deeply invasive 
histologically. It occurs in all populations but is most common in 
fair-skinned individuals, especially those with skin types 1 and 
2 that tan poorly or not at all. There is epidemiological evidence 
for the pathogenetic role of ultraviolet light, particularly intense 
childhood exposure, although the relationship is complex.1,2 
Genetic factors also play a role, as exemplified by families with 
both atypical naevi and melanoma.3
The rising incidence of melanoma, noted initially in 
countries with high levels of UV light, appears to be levelling 
off or decreasing in some areas.4 The pattern of these trends 
is inconsistent, with even European countries showing great 
variation.
An epidemiological study performed in Cape Town from 
1990 to 1995 demonstrated an incidence of melanoma of 
24.4 per 100 000 white people per annum.5 We conducted a 
methodologically identical study in the same geographical area 
after a 10-year interval, to identify whether there is a trend in 
the incidence of melanoma in this area.
Methods
A prospective case-based study was conducted from 1 January 
2001 to 31 December 2003. All histopathology reports of 
melanoma were obtained from all pathologists (private and 
public sector) serving the greater Cape Town area (as in the 
previous study).5
As the incidence of melanoma is low in dark-skinned 
individuals, the previous study was confined to white people. 
To obtain comparable data, the study population was defined 
in the same way in this study. Population figures for greater 
Cape Town (the study area as defined in the previous study) 
were based on the projected 2001 population, which estimated 
a denominator population of 441 970 whites above the age of 
14 years.6
Histopathology reports were reviewed for patients’ 
geographical area, gender, age, ethnic group, tumour site, Clark 
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level of invasion, Breslow thickness (mm), and histogenetic 
type (when available). Thickness was recorded in 3 arbitrary 
groups, as in the previous study (0 - 1.49, 1.5 - 3.49, and 3.5+ 
mm).
Reasons for exclusion from the study included living 
outside the designated area, if the tumour was not a primary 
melanoma, and if it was confined to the epidermis (in situ 
melanoma). The exclusion criteria used in this study (age 
under 14, secondary or in situ tumours, skin types IV - VI, 
residence outside the designated area) were identical to those 
applied in the previous study.5
Ethics approval was obtained from the Research Ethics 
Committee of the University of Cape Town.
Statistical analysis
The collected data were analysed using Stata statistical 
software.7 Age-standardised incidence rates were calculated 
by applying the world standard population.8 Incidence rates 
were considered significantly different if their 95% confidence 
interval (CI) did not overlap. Chi-squared tests were performed 
to compare the distribution of categorical data between the two 
studies. The analysis was performed by gender for tumour site, 
Clark level and Breslow thickness.
Results
Among the primary melanomas recorded during the 3-year 
study period, 443 satisfied the inclusion criteria and were 
further analysed. There were 234 (52.8%), in women, and 209 
(47.2%) in men. The overall age-standardised incidence rate per 
year was 33.5 per 100 000 (95% CI 29.1 - 37.8) for women, and 
36.9 (95% CI 31.9 - 41.9) for men. In the 1990 - 1995 study, the 
age-standardised rate for women was 22.2 (CI 19.6 - 24.9), and 
for men 27.5 (CI 24.3 - 30.7).  Therefore, the age-standardised 
rates show a significant rise in incidence of melanoma over the 
10-year period (1.5-fold among women and 1.3-fold among 
men). The increase is particularly marked in women under 35 
years.
Most tumours were found to invade to Clark level 2 and 
3 (71% of women and 69% of men). Deep tumours (level 5) 
were found in 3% of women and 1% of men (Table I). Breslow 
thickness of the tumours showed a similar pattern, with 
thinner tumours predominating, lesions of 0 - 1.49 mm being 
found in 78% of women and 74% of men. Tumours with a 
Breslow thickness >3.5 mm were seen in 10% of women and 
8% of men. The Clark level and Breslow thickness figures 
showed no significant change compared with the previous 
study.
Discussion
Our study demonstrates a significant increase in the incidence 
of melanoma among whites in Cape Town over a 10-year 
period (1.5-fold for women and 1.3-fold for men). The use 
of population census figures as a denominator might have 
lead to an error in estimates. However, a consistent increased 
incidence of melanoma in Cape Town was shown, whether 
applying the data from either of the Cape Town census periods 
(1991 and 1996) or the projected population figures for 2001. 
The projected population figure was applied in this study as it 
was thought likely to be the most accurate.
A rising incidence in melanoma has been reported in other 
countries over the last 30 years, although it is levelling off in 
some areas. Our study identifies Cape Town whites as having 
one of the highest occurrence rates in the world for new 
primary melanoma.
Recent figures for Australia show an incidence of 
approximately 48 and 34 per 100 000, for males and females 
respectively, but the rate in young women appears to be 
declining. There is little difference in incidence between Cape 
Town whites (particularly women) and people in the high-
prevalence areas of Australia, according to our current figures.
Where melanoma incidence rates have increased elsewhere, 
the rise in recent years has tended to be in thin tumours (<1.5 
mm). This may be due to earlier diagnosis, possibly as a result 
of greater awareness among doctors and the public. Education 
programmes may be contributing to this trend. The Cape 
Town figures do not demonstrate a disproportionate increase 
in thin tumours. The proportion of thin (<1.5 mm) and thick 
(>3.49 mm) tumours has remained constant (71 - 74% thin 
tumours in initial study, and 74 - 78% in later study, 8 - 10% 
thick tumours in both studies). These findings tend to suggest 
that the increased numbers in Cape Town reflect a genuine rise 
in the incidence of melanoma, rather than earlier diagnosis or 
inclusion of tumours at an earlier stage.
Gender and age differences in melanoma incidence have 
been observed in several countries. In Cape Town, the 
Table I. Percentage distribution of Clark level, comparing 
1990 - 1995 and 2001 - 2003 data sets
 1990 - 1995 2001 - 2003
 N (%) N (%)
Women
Clark level 2  114 (38.5)       88 (37.6)
3 95 (32.1)       77 (32.9)
4 76 (25.7)       63 (26.9)
5 11 (3.7)       6 (2.6)
Total 296 (100)       234 (100)
Chi-squared test (3 degrees of freedom) = 0.67, p = 0.880
Men 
Clark level 2  88 (29.4)       76 (36.4)
3   108 (36.1)      70 (33.5)
4   98 (32.8)       60 (28.7)
5   5 (1.7)       3 (1.4)
Total   299 (100)       209 (100)
Chi-squared test (3 degrees of freedom) = 2.77, p = 0.428
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melanoma incidence rate has risen more among women (1.5-
fold v. 1.3-fold in men).
How can the rising melanoma incidence among Cape Town 
whites be explained?
While incomplete data capture could theoretically have led 
to a misleadingly low figure in the earlier study, there is no 
reason to suggest that data capture in the 1990 - 1995 period 
differed from the present. It is more probable that the figures 
illustrate a true change in incidence. A possible loss of precision 
in our estimates might have resulted from the lesser timespan 
of 3 years of this study, in contrast to 6 years in the previous 
study, owing to financial constraints (that may be remedied by 
ongoing data capture).
A significant change in the genetic profile of whites in Cape 
Town is highly improbable. Increased UV light exposure seems 
the most plausible explanation for the trend, and may reflect 
childhood patterns of recreational exposure and/or increasing 
occupational exposure. Educational campaigns could be 
undertaken to reduce UV exposure, but their impact on 
lowering the incidence of melanoma has not yet been clearly 
established, and there would probably be a considerable lag 
phase. Further education of the public in Cape Town, targeting 
children in particular, may reduce the incidence of melanoma 
in this area in the future.
Melanoma is largely a disease of whites, who represent 
<20% of the population in South Africa. Infectious diseases, 
particularly tuberculosis and HIV/AIDS, affect large numbers 
of people, have a huge impact on individuals and the 
community, and place an enormous demand on the health 
budget of South Africa. Infectious disease will clearly require 
first priority for state health funding. However, in view of 
the poor outcome of advanced melanoma and the high costs 
of management, it is important to take appropriate steps to 
increase the detection of this potentially fatal disease at a 
curable stage. The increasing incidence of melanoma in Cape 
Town suggests that the modest resources necessary for such 
preventive steps can be justified.
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